Eradication of Cancer Cells Using Doxifluridine and Mesenchymal Stem Cells Expressing Thymidine Phosphorylase
Gene-directed enzyme prodrug therapy (GDEPT) has been developed over several decades as a targeted cancer treatment aimed at minimizing toxicity to healthy cells. This approach involves three key components: a non-toxic prodrug, a gene encoding an enzyme that converts the prodrug into an active chem...
Saved in:
| Main Authors: | Xutu Wang, Ian Peng, Ching-An Peng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-11-01
|
| Series: | Bioengineering |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2306-5354/11/12/1194 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Thymidine phosphorylase and its possible correlation with the lung cancer phenotype features
by: E. M. Bakurova, et al.
Published: (2015-04-01) -
The diagnostic value of IL-6 and thymidine phosphorylase in the progression of osteosarcoma
by: Bushra AM Abdul Azeez, et al.
Published: (2025-04-01) -
Thymidine phosphorylase in nucleotide metabolism: physiological functions and its implications in tumorigenesis and anti-cancer therapy
by: Bo Huang, et al.
Published: (2025-04-01) -
Correction: Thymidine phosphorylase in nucleotide metabolism: physiological functions and its implications in tumorigenesis and anti-cancer therapy
by: Bo Huang, et al.
Published: (2025-07-01) -
Renal impairment as a risk factor for chemotherapy induced neutropenia in the treatment of trifluridine/thymidine phosphorylase inhibitor plus bevacizumab
by: Masatsune Shibutani, et al.
Published: (2025-01-01)